Product Information
TRIAMCINOLONE 0.147 MG/G SPRAY is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $3.0584 per GM under NDC 45802004502. Its NADAC has been published 319 times since Apr 20, 2016.
FDA first approved this application on Apr 13, 2015. Its Orange Book therapeutic-equivalence code is AT.
Strength
.147 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802004502
Classification
Generic
Dosage Form
AEROSOL, SPRAY
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205782FDA Approved
4/13/2015
TE Code
AT
On Market Since
4/17/2015
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE 0.147 MG/G SPRAY has been published 319 times since Apr 20, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0584 per GM |
|---|---|
| All-time high | $3.1748 (Jul 15, 2026) |
| All-time low | $1.6948 (Oct 23, 2024) |
| 52-week high | $3.1748 |
| 52-week low | $2.1461 |
| Median price | $2.8307 |
| Average price | $2.6879 |
| Largest weekly change | +56.2% (Feb 19, 2025) |
| Weeks tracked | 319 |
| Tracking since | Apr 20, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE 0.147 MG/G SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE 0.147 MG/G SPRAY, manufactured by Padagis Israel Pharmaceuticals Ltd, is $3.0584 per GM (NDC 45802004502), effective Aug 19, 2026.
How has the price of TRIAMCINOLONE 0.147 MG/G SPRAY changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE 0.147 MG/G SPRAY has held within roughly two percent of its current level. It has been tracked across 319 weekly CMS publications since Apr 20, 2016.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE 0.147 MG/G SPRAY?
Since Apr 20, 2016, the NADAC for TRIAMCINOLONE 0.147 MG/G SPRAY has ranged from a low of $1.6948 (Oct 23, 2024) to a high of $3.1748 (Jul 15, 2026), with a median of $2.8307 per GM.
Are there cheaper alternatives to TRIAMCINOLONE 0.147 MG/G SPRAY?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE 0.147 MG/G SPRAY, is $1.9823 per GM — about 35% below TRIAMCINOLONE 0.147 MG/G SPRAY.
Who manufactures TRIAMCINOLONE 0.147 MG/G SPRAY?
TRIAMCINOLONE 0.147 MG/G SPRAY (NDC 45802004502) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.